Testing effectiveness (Phase 2)Ended earlyNCT00506779What this trial is testingGleevec/Taxol for Patients With Uterine Papillary Serous CarcinomaWho this might be right forUterine Cancer M.D. Anderson Cancer Center 17
Not applicableUnknownNCT01150682What this trial is testingRole of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial CancerWho this might be right forEndometrial Cancer Gynecologic Oncology Group 865
Testing effectiveness (Phase 2)Study completedNCT00551070What this trial is testingSelumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum CancerWho this might be right forBorderline Ovarian Serous TumorLow Grade Ovarian Serous AdenocarcinomaMicropapillary Serous Carcinoma+3 more National Cancer Institute (NCI) 52
Large-scale testing (Phase 3)Study completedNCT00002493What this trial is testingRadiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial CancerWho this might be right forEndometrial CancerPsychosocial Effects of Cancer and Its Treatment Gynecologic Oncology Group
Early research (Phase 1)WithdrawnNCT02050009What this trial is testingMetformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forOvarian Papillary Serous CarcinomaOvarian Serous CystadenocarcinomaRecurrent Fallopian Tube Cancer+3 more Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00147680What this trial is testingUterine Papillary Serous Cancer (UPSC) TrialWho this might be right forUterine Cancer Queensland Centre for Gynaecological Cancer 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04095364What this trial is testingLetrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forLow Grade Fallopian Tube Serous AdenocarcinomaOvarian Low Grade Serous AdenocarcinomaPrimary Peritoneal Low Grade Serous Adenocarcinoma+9 more NRG Oncology 450
Large-scale testing (Phase 3)Study completedNCT00003749What this trial is testingSurgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial CancerWho this might be right forEndometrial Cancer Medical Research Council 2,300
Testing effectiveness (Phase 2)Study completedNCT00416455What this trial is testingFludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial CancerWho this might be right forCervical AdenocarcinomaCervical Adenosquamous Cell CarcinomaCervical Small Cell Carcinoma+11 more National Cancer Institute (NCI) 384
Testing effectiveness (Phase 2)Study completedNCT00231868What this trial is testingRadiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous CarcinomaWho this might be right forUterine Cancer Montefiore Medical Center 81
Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Testing effectiveness (Phase 2)Active Not RecruitingNCT03531645What this trial is testingFulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous CarcinomaWho this might be right forMalignant Neoplasms of Female Genital Organs M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00052312What this trial is testingDoxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial CancerWho this might be right forEndometrial Cancer European Organisation for Research and Treatment of Cancer - EORTC 141
Testing effectiveness (Phase 2)Study completedNCT00025467What this trial is testingThalidomide in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04575961What this trial is testingStudy of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian CancerWho this might be right forOvarian CancerLow Grade Serous CarcinomaPrimary Peritoneal Carcinoma+1 more North Eastern German Society of Gynaecological Oncology 33
Testing effectiveness (Phase 2)Ended earlyNCT00653328What this trial is testingPh II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary AdenocarcinomaWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer Vanderbilt-Ingram Cancer Center 15
Large-scale testing (Phase 3)Study completedNCT00006027What this trial is testingComparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial CancerWho this might be right forEndometrial Cancer Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00664781What this trial is testingRucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian CancerWho this might be right forbrca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more Cancer Research UK 78
Large-scale testing (Phase 3)Study completedNCT00005583What this trial is testingRadiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial CancerWho this might be right forEndometrial Cancer Nordic Society of Gynaecological Oncology - Clinical Trials Unit 400
Early research (Phase 1)Study completedNCT01198184What this trial is testingGamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid TumorsWho this might be right forEndometrial Papillary Serous CarcinomaRecurrent Endometrial CarcinomaRecurrent Renal Cell Cancer+5 more National Cancer Institute (NCI) 18